logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
20/04/2026
Hong Kong stock group CoreTech continues to rise, now up over 100%.
Latest
4 m ago
AstraZeneca's IL-33 targeting biologic agent tozorakimab has achieved positive results in the third pivotal phase III clinical trial. The results show that tozorakimab significantly and clinically improved the annual rate of moderate to severe acute exacerbations in patients with chronic obstructive pulmonary disease (COPD), both in the primary study population (former smokers) and the overall population (including both former and current smokers, and covering patients with all blood eosinophil levels and all levels of lung function severity grading).
5 m ago
Ruijie Networks: Net profit in the first quarter was 123 million yuan, an increase of 14.59% year-on-year.
6 m ago
Report: Toyota and Ningde Times will collaborate to produce hybrid vehicle batteries in Indonesia.
8 m ago
Longfor Group's 5 billion yuan corporate bond application is terminated: will change intermediaries and reapply.
9 m ago
Japan says there are no abnormalities at the Onagawa Nuclear Power Station and the Fukushima Daiichi Nuclear Power Station.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.